Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder

CMAJ. 2024 Mar 17;196(10):E346-E347. doi: 10.1503/cmaj.149917-l.NO ABSTRACTPMID:38499302 | PMC:PMC10948180 | DOI:10.1503/cmaj.149917-l

Source: Canadian Medical Association Journal - March 18, 2024 Category: General Medicine Authors: Anees Bahji Marlon Danilewitz Matthew Sloan Victor Tang David Crockford Source Type: research